Start-up meeting associated with initiation of clinical studies of Ergoferon

Start-up meeting associated with initiation of two international multicenter double blind placebo-controlled randomized clinical studies of Ergoferon was carried out on April 7-8 in Sochi

Efficacy and safety of the drug in the treatment of acute respiratory viral infections in children shall be investigated in 17 clinical sites of Russia, Kazakhstan and the Republic of Belarus. Another clinical study with scheduled 13 clinical sites in Russia, Kazakhstan, the Republic of Belarus and Uzbekistan will allow to obtain additional data on efficacy and safety of Ergoferon in the treatment of intestinal infections of viral etiology. In total the studies shall enroll 860 subjects aged 6 months - 7 years old receiving therapy in polyclinics and hospitals.